BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 921243)

  • 21. Comparative synergistic activity of nafcillin, oxacillin, and methicillin in combination with gentamicin against.
    Glew RH; Millering RS; Wennersten C
    Antimicrob Agents Chemother; 1975 Jun; 7(6):828-32. PubMed ID: 1155924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J; Kaye D
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillinase-resistant penicillin/gentamicin synergism. Effect in patients with Staphylococcus aureus bacteremia.
    Licht JH
    Arch Intern Med; 1979 Oct; 139(10):1094-8. PubMed ID: 258599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Pierre J; Castéla-Papin N; Saint-Julien L; Drugeon H; Farinotti R; Carbon C
    Antimicrob Agents Chemother; 1996 May; 40(5):1219-24. PubMed ID: 8723470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.
    Henry NK; Wilson WR; Geraci JE
    Antimicrob Agents Chemother; 1986 Nov; 30(5):725-8. PubMed ID: 3800348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.
    Miller MH; Wexler MA; Steigbigel NH
    Antimicrob Agents Chemother; 1978 Sep; 14(3):336-43. PubMed ID: 251069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    Sande MA; Johnson ML
    J Infect Dis; 1975 Apr; 131(4):367-75. PubMed ID: 1117194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
    Fernandez-Guerrero M; Rouse MS; Henry NK; Geraci JE; Wilson WR
    Antimicrob Agents Chemother; 1987 Mar; 31(3):430-3. PubMed ID: 3579260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy.
    Sacher HL; Miller WC; Landau SW; Sacher ML; Dixon WA; Dietrich KA
    J Clin Pharmacol; 1991 Aug; 31(8):719-21. PubMed ID: 1908863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F; Martín-Luengo F; García A; Valdés M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of enterococcal infections.
    Eliopoulos GM; Eliopoulos CT
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):118-26. PubMed ID: 2180707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of sisomicin and netilmicin alone and in combination with nafcillin, oxacillin and methicillin against enterococci.
    Watanakunakorn C; Glotzbecker C
    Chemotherapy; 1978; 24(4):236-9. PubMed ID: 648236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis.
    Goldstein JA; Cohen H; Bia FJ
    Yale J Biol Med; 1983; 56(3):243-9. PubMed ID: 6659563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
    Marangos MN; Nicolau DP; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1997 Apr; 39(4):519-22. PubMed ID: 9145826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1984; 42():110-6. PubMed ID: 6442009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penicillin combined with gentamicin or streptomycin: synergism against enterococci.
    Watanakunakorn C
    J Infect Dis; 1971 Dec; 124(6):581-6. PubMed ID: 5209849
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Enterococcal endocarditis.
    Portnoy J; Mendelson J
    Can Med Assoc J; 1974 Nov; 111(10):1053-4. PubMed ID: 4429930
    [No Abstract]   [Full Text] [Related]  

  • 40. Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy.
    Levine JF; Hanna BA; Pollock AA; Simberkoff MS; Rahal JJ
    Am J Med Sci; 1983; 286(1):31-6. PubMed ID: 6553451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.